Error: Could not add to watchlist. X
+ Watchlist

AXA Framlington Biotech Fund

FRABIRA:LN
101.70
USd
0.40
0.39%
As of 12:59 AM EDT 5/26/2017
Fund Type
Unit Trust
52Wk Range
86.85 - 106.30
YTD Return
7.22%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
102.10
52Wk Range
86.85 - 106.30
YTD Return
7.22%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 05/26/2017)
101.7
Total Assets (m GBP) (on 05/26/2017)
508.038
Inception Date
01/23/2015
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
-
Expense Ratio
-

Top Fund Holdings

Name Position Value % of Fund
510.08 k 48.86 m 9.20
812.69 k 43.02 m 8.10
205.41 k 43.02 m 8.10
355.24 k 35.05 m 6.60
199.36 k 24.96 m 4.70
74.36 k 22.31 m 4.20
152.54 k 21.78 m 4.10
287.05 k 21.24 m 4.00
182.62 k 17.53 m 3.30
168.60 k 15.40 m 2.90
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
Address
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
Phone
44-207-374-4100